Further, indirect downregulation of MYC via ubiquitin–proteasome mechanisms is an excellent strategy for targeting CSCs, for instance activating SCFFBXW7 [54] and inhibiting deubiquitinase USP28 of MYC suppresses cell proliferation in diverse cancer [55]. Here, MYC is linked to cancer.